Senti Biosciences Holdings, Inc. — Form D

Senti Biosciences Holdings, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-04. The offering totals $40.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-06-04
• Form: D
• Accession: 0001193125-26-256064
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $40.0M
• Amount sold: $10.0M
• Remaining: $30.0M
• Investors: 1
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-586137

Issuer

• Name: Senti Biosciences Holdings, Inc.
• CIK: 0001854270
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 2 Corporate Drive, First Floor, South San Francisco, CA, 94080
• Phone: 650-239-2030

Officers, directors & promoters (19)

Other filings by this issuer (1)

More

• CIK 1854270 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search